How to Source Non-IMP Supplies for Clinical Trials
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP...
Tim Holmes, Manager, Clinical Oversight of Supplies, Biogen, offers considerations on how to obtain non-IMP...
Hedley Rees, Chief Disruptor, PharmaFlow, discusses the need for a rethink on supply chain processes
Francesco Spoto, Clinical Project Manager, explores the opportunities of using IRT solutions to manage blinded...
Mainfong Ang, Amgen, sits down with CTA’s Jisong Seo about the difficulties of clinical operations...
Barrett Glasser, Associate Director, Clinical Drug Supply, Biogen, provides an overview on how to on...
Ian Hoban, Pilatus Comparator Solutions, poses some key questions that should be front of mind...
Peter Shapiro, Editor-In-Chief, PharmSource, a GlobalData Product, assesses key trends currently changing the face of...
Jesper Franke, Head of Healthcare, GS1 Denmark, explains how the industry can best improve supply...
Anthony Zuccarello, Associate Director, IRT and Global Clinical Supply Strategy, Amicus Therapeutics, offers insight on...
Clive E. Badman, OBE, talks to CTA’s Charlie Abrines about the digitization of the clinical...